Venture Funding Deals: Cell Medica Raises $73.2m, Tango Dances In With $55m

16 May 2017

• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Novel approaches to infectious diseases and cancer garnered significant VC cash in recent months, including monoclonal antibodies to treat and prevent S. aureus, Cell Medica's next-generation T cell therapies and Tango's platform focused on genetic drivers of cancer.

Venture Funding Deals: Cell Medica Raises $73.2m, Tango Dances In With $55m

More from Financing

More from Business